FIBTEM provides early prediction of massive transfusion in trauma
Top Cited Papers
Open Access
- 11 November 2011
- journal article
- Published by Springer Nature in Critical Care
- Vol. 15 (6) , R265
- https://doi.org/10.1186/cc10539
Abstract
Introduction: Prediction of massive transfusion (MT) among trauma patients is difficult in the early phase of trauma management. Whole-blood thromboelastometry (ROTEM®) tests provide immediate information about the coagulation status of acute bleeding trauma patients. We investigated their value for early prediction of MT. Methods: This retrospective study included patients admitted to the AUVA Trauma Centre, Salzburg, Austria, with an injury severity score ≥16, from whom blood samples were taken immediately upon admission to the emergency room (ER). ROTEM® analyses (extrinsically-activated test with tissue factor (EXTEM), intrinsically-activated test using ellagic acid (INTEM) and fibrin-based extrinsically activated test with tissue factor and the platelet inhibitor cytochalasin D (FIBTEM) tests) were performed. We divided patients into two groups: massive transfusion (MT, those who received ≥10 units red blood cell concentrate within 24 hours of admission) and non-MT (those who received 0 to 9 units). Results: Of 323 patients included in this study (78.9% male; median age 44 years), 78 were included in the MT group and 245 in the non-MT group. The median injury severity score upon admission to the ER was significantly higher in the MT group than in the non-MT group (42 vs 27, P < 0.0001). EXTEM and INTEM clotting time and clot formation time were significantly prolonged and maximum clot firmness (MCF) was significantly lower in the MT group versus the non-MT group (P < 0.0001 for all comparisons). Of patients admitted with FIBTEM MCF 0 to 3 mm, 85% received MT. The best predictive values for MT were provided by hemoglobin and Quick value (area under receiver operating curve: 0.87 for both parameters). Similarly high predictive values were observed for FIBTEM MCF (0.84) and FIBTEM A10 (clot amplitude at 10 minutes; 0.83). Conclusions: FIBTEM A10 and FIBTEM MCF provided similar predictive values for massive transfusion in trauma patients to the most predictive laboratory parameters. Prospective studies are needed to confirm these findings.Keywords
This publication has 37 references indexed in Scilit:
- Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgeryBritish Journal of Anaesthesia, 2010
- Postinjury Coagulopathy ManagementAnnals of Surgery, 2010
- Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Diagnosis and management of coagulopathy after major traumaBritish Journal of Surgery, 2009
- Massive Transfusion Protocols: The Role of Aggressive Resuscitation Versus Product Ratio in Mortality ReductionJournal of the American College of Surgeons, 2009
- Early evaluation of acute traumatic coagulopathy by thrombelastographyTranslational Research, 2009
- Hyperfibrinolysis After Major Trauma: Differential Diagnosis of Lysis Patterns and Prognostic Value of ThrombelastometryJournal of Trauma: Injury, Infection & Critical Care, 2009
- Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometryBJOG: An International Journal of Obstetrics and Gynaecology, 2009
- Early Prediction of Massive Transfusion in Trauma: Simple as ABC (Assessment of Blood Consumption)?Journal of Trauma: Injury, Infection & Critical Care, 2009
- A Predictive Model for Massive Transfusion in Combat Casualty PatientsJournal of Trauma: Injury, Infection & Critical Care, 2008